Elizabeth Weise, The Tennessean

Elizabeth Weise

The Tennessean

San Francisco, CA, United States

Contact Elizabeth

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • The Tennessean
  • USA TODAY
  • Enquirer
  • Times Record News
  • The Columbus Dispatch
  • Silver City Sun-News
Past:
  • Alamogordo DailyNews
  • DelmarvaNow!
  • The News Leader
  • North Jersey News
  • Daily Record
  • BlueRidgeNow
  • delawareonline
  • The Spectrum
  • Statesman Journal
  • argusleader
  • and more…

Recent articles by Elizabeth:

Scientists outraged by White House appointees' meddling with coronavirus information: 'Outright egregious'

Scientists 'aghast' over news of White House meddling with public health reports that conflict with President Donald Trump's coronavirus messaging. → Read More

The sprint to create a COVID-19 vaccine started in January. The finish line awaits.

Drug developers confronting the coronavirus pandemic are fueled by coffee, competitiveness and a chance to protect the world. → Read More

COVID vaccine candidate developed by Oxford University and AstraZeneca put on hold after 'unexplained illness'

The interruption in testing the Oxford vaccine candidate represents the first major hiccup in a remarkably smooth effort to create a COVID-19 vaccine. → Read More

With Trump promising a COVID-19 vaccine 'very soon,' industry developers pledge to keep politics out of science

Could a vaccine arrive before the election? Nine vaccine developers are pledging to fully vet their COVID-19 candidate vaccines before asking for FDA approval. → Read More

'Mind-bogglingly complex': Here's what we know about how COVID vaccine will be distributed when it's approved

We don’t know when a COVID-19 vaccine will arrive, but we’re starting to understand how it will be distributed. → Read More

Report: Coronavirus vaccine shouldn't be first-come, first-served

A coronavirus vaccine would be scarce when it first arrives, so it should go first to health care workers, paramedics, firefighters and police. → Read More

Coronavirus vaccine on track for FDA approval by end of 2020, says Operation Warp Speed official

The United States expects to have four coronavirus candidate vaccines in large-scale clinical trials by the middle of September, a remarkable → Read More

Coronavirus vaccine on track for FDA approval by end of 2020, says Operation Warp Speed official

The United States expects to have four coronavirus candidate vaccines in Phase 3 clinical trials by the middle of September. → Read More

CDC clarifies surprise guidelines that people without COVID-19 symptoms don't need testing

The CDC on Thursday attempted to clarify controversial coronavirus testing guidelines saying people with no symptoms do not necessarily need a test. → Read More

Experts see progress on a COVID vaccine, but worry about who gets it first and how it gets to them

Public confidence in effectiveness and delivery of COVID vaccines must be established for battle against the pandemic to succeed, says our panel. → Read More

Federal government wants COVID vaccine distribution system in place and ready to roll by Nov. 1

To prepare for deadline, test runs will start next month on logistics to distribute millions of doses of vaccine in the US, says UPS official → Read More

Texas-based McKesson tapped to help get coronavirus vaccines into American communities

The U.S. government has chosen medical supplier McKesson to be a centralized distributor for future coronavirus vaccines. → Read More

Federal spending on COVID-19 vaccine candidates tops $9 billion, spread among 7 companies

Amid the coronavirus pandemic, the federal government has allocated more than $9 billion among 7 companies to develop and make COVID-19 vaccine. → Read More

Scientists have figured out why so many COVID-19 patients lose their sense of smell

Scientists have figured out how COVID-19 causes many people to lose their sense of smell. And they have good news — the loss appears to be temporary because the actual cells in the nose that detect smell aren’t harmed.Temporary loss of smell is called "anosmia" by doctors. It's one of the earliest and most commonly reported indicators of COVID-19. In fact, studies suggest it’s a better predictor… → Read More

Why do so many COVID patients lose their sense of smell? Scientist now know.

Turns out the loss experienced by many who contract COVID is temporary because the neurons that detect smell aren’t hurt. → Read More

CDC COVID-19 advice tells schools to wash hands, wear masks, don't touch. But not when to close

Parent check-list for back-to-school: Label your child's face mask with permanent marker. Practice hand washing. → Read More

New CDC guidelines say people with mild to moderate COVID-19 only need to isolate 10 days

COVID-19 patients with mild to moderate disease only need to isolate for 10 days after their symptoms begin and don't need to be retested. → Read More

Early success of COVID-19 vaccine candidates fuels optimism, but experts warn 'a lot has to go right'

USA TODAY created a panel of experts to estimate how far we are from when a COVID-19 vaccine will be available to all Americans. → Read More

Top COVID-19 vaccine makers say safe, effective and low-cost candidates possible by early 2021

Lawmakers press coronavirus vaccine makers for assurances the speed of development won't compromise safety, regardless of government regulation. → Read More

Wearing a mask doesn't just protect others from COVID, it protects you from infection, perhaps serious illness, too

At a Missouri hair salon, mask wearing seems to have kept clients exposed to two stylists with COVID-19 from getting infected. → Read More